David Jackson

Trials

Studies that name David Jackson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:46 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06666504 · The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

  Guy's and St Thomas' NHS Foundation Trust · completed · Severe Asthma · principal investigator
• N/A
  NCT05847452 · Beyond the Eosinophil: Understanding the Impact of Eosinophil Depletion on T2 Inflammation. (BEUTI)

  Guy's and St Thomas' NHS Foundation Trust · unknown · Asthma · principal investigator
• Ph4
  NCT04159519 · A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

  AstraZeneca · completed · Asthma, Severe Eosinophilic Asthma · principal investigator
• N/A
  NCT00289068 · Phacoemulsification Sleeves

  University of Oklahoma · completed · Cataract · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 7 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.